Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts
about
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasmsRevisiting the case for genetically engineered mouse models in human myelodysplastic syndrome researchDiscovery of a clinical stage multi-kinase inhibitor sodium (E)-2-{2-methoxy-5-[(2',4',6'-trimethoxystyrylsulfonyl)methyl]phenylamino}acetate (ON 01910.Na): synthesis, structure-activity relationship, and biological activityRecent advances in the understanding of myelodysplastic syndromes with ring sideroblasts.Dysplasia features of myelodysplastic syndrome in ethnically Chinese people.Clinical Prognostic Factors in 86 Chinese Patients with Primary Myelodysplastic Syndromes and Trisomy 8: A Single Institution Experience.Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance.Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers.Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia.Distinct clinical and experimental characteristics in the patients younger than 60 years old with myelodysplastic syndromes.Computerized texture analysis of atypical immature myeloid precursors in patients with myelodysplastic syndromes: an entity between blasts and promyelocytes.SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors.Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET studySF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes.SF3B1 mutant MDS-initiating cells may arise from the haematopoietic stem cell compartment.Complete Remission of del(5q) Myelodysplastic Syndrome after 7 Days of Lenalidomide Therapy Gives an Alert!Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts.Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes.Spliceosome mutations exhibit specific associations with epigenetic modifiers and proto-oncogenes mutated in myelodysplastic syndromeSF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic valueFlow Cytometry in the Diagnosis of Myelodysplastic SyndromesDiagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.TET2 plays an essential role in erythropoiesis by regulating lineage-specific genes via DNA oxidative demethylation in a zebrafish model.Azacitidine: activity and efficacy as an epigenetic treatment of myelodysplastic syndromes.An examination of educational gaps in the diagnosis and treatment of myelodysplastic syndromes.Standards and impact of hematopathology in myelodysplastic syndromes (MDS).Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.Myeloid leukemia cutis in the setting of myelodysplastic syndrome: a crucial dermatological diagnosis.Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms.Emerging immunosuppressive drugs in myelodysplastic syndromes.Role of flow cytometry in myelodysplastic syndromes: diagnosis, classification, prognosis and response assessment.WHO classification of myeloproliferative neoplasms (MPN): A critical update.Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes.Diagnosing and following adult patients with acute myeloid leukaemia in the genomic age.Gingival enlargement in myelodysplastic syndrome.Importance of classical morphology in the diagnosis of myelodysplastic syndrome.Preclinical modeling of myelodysplastic syndromes.Validation of the revised International Prognostic Scoring System in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registry.A retrospective study evaluating the impact of infectious complications during azacitidine treatment.
P2860
Q24629306-6065D128-C1A0-4377-AE8C-BA4A1B677828Q26859843-A1CFBD3E-4160-4932-B44B-22379A54E688Q28244790-FA5FADAA-9434-43D4-9F37-4A6413237C57Q30249108-7A2BE81C-9672-48EA-8559-9D6751FDD248Q33411124-8F3EAE26-F5FE-4D03-9D97-FC71E96669B0Q33429792-0F3F02BB-3A03-45F5-8CAF-C4810D852643Q33841401-DA7D0147-F438-4F7E-B0B9-992E2ABA70EEQ33843996-E4E7D4B5-84BC-4DBD-84B2-B7D8BAB45DB4Q34106883-479C0030-B4BA-463A-B6D2-FA712CB057BFQ34612063-D1866E9C-20F8-442F-B8C0-807952D6E336Q35373199-4AA63486-E778-45C0-A7F8-15B6DC20E345Q35925679-DE42F9C5-B69D-4E61-8155-BDD435EA3995Q35930609-152C5F7E-8E04-4B0A-8BB6-B675465DE896Q36133023-2E0C303A-6AEC-447C-AC84-EF606DABDBFFQ36333518-AF195C33-7EB8-444D-A4A0-5F7E529D2A09Q36392053-7ACC38DB-1AD4-451C-81B1-BA5924424E36Q36422512-8125BB82-2FFF-46D2-8311-030F66FF0CD3Q36799748-D12A9574-85F0-486F-81D5-8ECEEA02C481Q36862492-EAACB327-927F-4560-857E-EEC4B44E7F09Q36967122-6C923EBC-FA43-462A-8034-6BA25ED726F0Q37027772-B1AE672E-AB90-4E3D-8B2E-CF2273D38B69Q37155338-59E46871-0E49-454A-8DB0-0AA8DF3156C7Q37263146-CD97E1C9-E07A-406D-AC03-1E7363959030Q37643944-EEB6084E-3EC3-477C-AE8E-D58CD94D36CEQ37810265-1AA2C3D0-B1B3-4A37-A986-565F62298B9EQ37832936-D53FD610-248E-4D25-81A7-6CD39C31E2E5Q37840934-5C7CA725-C07F-4742-8083-CF29764189EBQ37889846-45F50405-D0A4-48EB-93FB-9340DE8DFDD1Q37995656-D3A7A700-13BA-4A6D-9DB0-D29A561A22E5Q38060535-4305C833-26C2-4A23-9793-D27CC9AE4961Q38060835-D9FE963F-A991-4971-BCA0-CD1E05BE5807Q38117677-F76A6281-39CF-4806-B8CD-152581149509Q38154519-AB6E78B4-5AAD-4D40-AFE0-E33417BA8697Q38220788-792CF964-1FE4-484E-ABF2-9010CC912BA2Q38240563-8DDB588D-983B-402F-8BFB-2692F1B26686Q38440284-BBD283C9-383D-49BE-88E6-C492CEFD8E82Q38471249-F2B81FDA-8E9B-4F73-9148-9FE52CF98171Q38701479-8068B987-2F1E-434C-92F5-238BA0B578D2Q38790168-0ACBE59F-0E00-47B3-AC1A-C8661947D32AQ38803021-EEE6E231-7665-40BE-9302-1B8A3768685F
P2860
Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Diagnosis and classification o ...... loblasts and ring sideroblasts
@ast
Diagnosis and classification o ...... loblasts and ring sideroblasts
@en
Diagnosis and classification o ...... loblasts and ring sideroblasts
@nl
type
label
Diagnosis and classification o ...... loblasts and ring sideroblasts
@ast
Diagnosis and classification o ...... loblasts and ring sideroblasts
@en
Diagnosis and classification o ...... loblasts and ring sideroblasts
@nl
prefLabel
Diagnosis and classification o ...... loblasts and ring sideroblasts
@ast
Diagnosis and classification o ...... loblasts and ring sideroblasts
@en
Diagnosis and classification o ...... loblasts and ring sideroblasts
@nl
P2093
P50
P356
P1433
P1476
Diagnosis and classification o ...... loblasts and ring sideroblasts
@en
P2093
Akira Matsuda
Atsushi Manabe
Ayami Yoshimi
Barbara J Bain
Charlotte M Niemeyer
Eva Hellström-Lindberg
Ghulam J Mufti
Guillermo Sanz
Irith Baumann
Itsuro Jinnai
P304
P356
10.3324/HAEMATOL.13405
P407
P577
2008-11-01T00:00:00Z